Thought Leader Liaison – Neurology (Rare Disease) – Remote

Otsuka America Pharmaceutical Inc.; Hagåtña (GU); Remote; USD 169.000 - 253.000; Vollzeit

Benefits dieser Stelle

Comprehensive medical benefits

401(k) match

Paid time off & holidays

Zusammenfassung

Otsuka America Pharmaceutical Inc. seeks an Associate Director, Thought Leader Liaison (TLL) in the Neurology Rare Disease area.

This senior, field-based, non-sales role partners with Marketing and Medical Affairs to engage national and regional thought leaders, map referral pathways, and develop disease education initiatives. The TLL addresses barriers to recognition, testing and referral while ensuring pre-launch and post-approval education remains compliant and impactful.

Qualifikationen

• Senior, field-based, externally facing non-sales role.
• Minimum eight years biopharmaceutical or equivalent experience in related roles.
• Experience with neurology, rare/disease, or genetics preferred.
• Pre-launch and post-approval engagement experience.
• Ability to operate independently in a field setting.

Aufgaben

• Develop regional strategy and engagement plans aligned with national priorities.
• Map and engage priority thought leaders and institutions.
• Collaborate with Marketing and Medical Affairs to translate insights into action.
• Lead or coordinate non-promotional disease education and market development activities.
• Travel as required, with proficiency in cross-functional execution.

Kenntnisse

Leadership

Strategic thinking

Problem solving

Patient centricity

Communication

Stakeholder management

Cross-functional collaboration

Ability to travel

CRM & analytics

Ausbildung

Bachelor’s degree

Tools

CRM

Insight management

Virtual engagement

Jobbeschreibung

Otsuka America Pharmaceutical Inc. seeks an Associate Director, Thought Leader Liaison (TLL) in the Neurology Rare Disease area.

This senior, field-based, non-sales role partners with Marketing and Medical Affairs to engage national and regional thought leaders, map referral pathways, and develop disease education initiatives. The TLL addresses barriers to recognition, testing and referral while ensuring pre-launch and post-approval education remains compliant and impactful.